Breaking News
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease

The FDA has cleared an Investigational New Drug (IND) application for SB-007, an adeno-associated vi...

read more
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease
December 13, 2024
Bausch + Lomb Acquires ELIOS System, Expanding Glaucoma Treatment Options

Bausch + Lomb Corp. has announced the acquisition of Elios Vision Inc., the developer of the ELIOS p...

read more
Bausch + Lomb Acquires ELIOS System, Expanding Glaucoma Treatment Options
December 12, 2024
Adverse Effects Identified Following Faricimab Treatment for Eye Conditions

Researchers from the University Hospital Zurich have reported cases of sterile intraocular inflammat...

read more
Adverse Effects Identified Following Faricimab Treatment for Eye Conditions
October 15, 2024
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved Products

The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Ey...

read more
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved Products
September 19, 2024
Maestro®: The Sinusoidal IOL

VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovati...

read more
Maestro®: The Sinusoidal IOL
September 18, 2024
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024

This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the c...

read more
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
September 05, 2024
European Commission Approves Akantior as First Treatment for Acanthamoeba Keratitis

The European Commission (EC) has officially approved Avanzanite Bioscience's Akantior (polihexanide)...

read more
European Commission Approves Akantior as First Treatment for Acanthamoeba Keratitis
September 02, 2024
ViaLase Laser Receives CE Mark Approval for Glaucoma Treatment

ViaLase has received CE Mark approval in the European Union for its ViaLase laser, designed to treat...

read more
ViaLase Laser Receives CE Mark Approval for Glaucoma Treatment
July 31, 2024
Bausch + Lomb Acquires Trukera Medical to Enhance Surgical Capabilities

Bausch + Lomb has completed the acquisition of Trukera Medical, a US-based ophthalmic medical diagno...

read more
Bausch + Lomb Acquires Trukera Medical to Enhance Surgical Capabilities
July 24, 2024
Oertli Instrumente Receives FDA Clearance for Faros Anterior Cataract Surgery System

Oertli Instrumente AG announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

read more
Oertli Instrumente Receives FDA Clearance for Faros Anterior Cataract Surgery System
July 24, 2024
More